NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

SC3 - Secure, clean and efficient energy

The Energy Challenge is designed to support the transition to a reliable, sustainable and competitive energy system. To make the transition to a competitive energy system, we need to overcome a number of challenges, such as increasingly scarce resources, growing energy needs and climate change.

Your NCP contact for this programme

Image of Ria De Breucker

Ria De Breucker

Ria.debreucker@vlaio.be

+32 2 553 13 77

About this programme

The Energy Challenge is designed to support the transition to a reliable, sustainable and competitive energy system.

To make the transition to a competitive energy system, we need to overcome a number of challenges, such as increasingly scarce resources, growing energy needs and climate change.

The Energy Challenge is structured around seven specific objectives and research areas:

  • Reducing energy consumption and carbon footprint
  • Low-cost, low-carbon electricity supply
  • Alternative fuels and mobile energy sources
  • A single, smart European electricity grid
  • New knowledge and technologies
  • Robust decision making and public engagement
  • Market uptake of energy and ICT innovation.
Click to read more 
Hide text 

Latest news

Upcoming events

No events that are specifically related to SC3 - Secure, clean and efficient energy were found. Check the full calendar.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.